In the STEP-1 trial (N=1,961), adults receiving semaglutide 2.4 mg lost 14.9% of body weight at 68 weeks versus 2.4% with placebo [1]
The FDA defines biosimilar interchangeability as requiring a higher standard than mere similarity: an interchangeable biosimilar must produce the same clinical result as the reference product in any given patient, and for products administered more than once, the risk of switching must be no greater than continuing on the reference product
Food is relational
CLIA Certificate: Any provider or facility billing for these services must possess the appropriate Clinical Laboratory Improvement Amendments (CLIA) certificate matching the complexity of the test performed (e.g., CLIA Waived for 80305 POC)
Monitor Your Symptoms : If vomiting continues for more than 24 hours, if theres blood in your stool, or if youre unable to keep fluids down, its time to call your doctor
Embark on your health journey today with a streamlined, supportive telehealth experience